86 related articles for article (PubMed ID: 27102074)
1. BRAF-Like Colorectal Cancer Cells Are Selectively Dependent on RANBP2.
Cancer Discov; 2016 Jun; 6(6):OF18. PubMed ID: 27102074
[TBL] [Abstract][Full Text] [Related]
2. [Mitotic nucleoporin orchestrates colorectal carcinogenesis].
Hashizume C; Minamoto T; Wong RW
Seikagaku; 2016 Dec; 88(6):748-51. PubMed ID: 29624348
[No Abstract] [Full Text] [Related]
3. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
4. MAFG mediates CIMP in BRAF-mutant colorectal cancer.
Cancer Discov; 2014 Nov; 4(11):OF11. PubMed ID: 25367952
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells.
Sueda T; Sakai D; Kawamoto K; Konno M; Nishida N; Koseki J; Colvin H; Takahashi H; Haraguchi N; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Satoh T; Doki Y; Mori M; Ishii H
Sci Rep; 2016 Jan; 6():18949. PubMed ID: 26750638
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
7. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
8. Co-existence of BRAF V600E Gene Mutation in Tumor and Non-tumoral Surrounding Tissues in Colorectal Cancer.
Öztürk T; Toptaş-Hekimoğlu B; Eronat AP; Saygili N; Dağlar-Aday A; Başsüllü N; Türkmen I; Aydoğan HY; Bülbül G; Göksel S; Öztürk O; Isbir T
In Vivo; 2015; 29(5):577-84. PubMed ID: 26359417
[TBL] [Abstract][Full Text] [Related]
9. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications.
Sclafani F; Gullo G; Sheahan K; Crown J
Crit Rev Oncol Hematol; 2013 Jul; 87(1):55-68. PubMed ID: 23246082
[TBL] [Abstract][Full Text] [Related]
12. A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.
Vecchione L; Gambino V; Raaijmakers J; Schlicker A; Fumagalli A; Russo M; Villanueva A; Beerling E; Bartolini A; Mollevi DG; El-Murr N; Chiron M; Calvet L; Nicolazzi C; Combeau C; Henry C; Simon IM; Tian S; in 't Veld S; D'ario G; Mainardi S; Beijersbergen RL; Lieftink C; Linn S; Rumpf-Kienzl C; Delorenzi M; Wessels L; Salazar R; Di Nicolantonio F; Bardelli A; van Rheenen J; Medema RH; Tejpar S; Bernards R
Cell; 2016 Apr; 165(2):317-30. PubMed ID: 27058664
[TBL] [Abstract][Full Text] [Related]
13. The BRAF mutation in MLH1-deficient colorectal cancer.
Mahesh SA
Clin Adv Hematol Oncol; 2013 Apr; 11(4):234-6. PubMed ID: 23604240
[No Abstract] [Full Text] [Related]
14. Impact of KRAS and BRAF gene mutations on targeted therapies in colorectal cancer.
Bass A
J Clin Oncol; 2011 Jul; 29(19):2728-9. PubMed ID: 21646605
[No Abstract] [Full Text] [Related]
15. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
Li WQ; Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Iacopetta B
Mol Cancer; 2006 Jan; 5():2. PubMed ID: 16403224
[TBL] [Abstract][Full Text] [Related]
16. KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer.
Li HT; Lu YY; An YX; Wang X; Zhao QC
Oncol Rep; 2011 Jun; 25(6):1691-7. PubMed ID: 21424126
[TBL] [Abstract][Full Text] [Related]
17. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer.
Hirschi B; Kolligs FT
Int J Cancer; 2013 Aug; 133(3):590-6. PubMed ID: 23354951
[TBL] [Abstract][Full Text] [Related]
19. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and B-type Raf proto-oncogene mutation in colorectal cancer: Clinicopathological characteristics and effects on survival.
Batur S; Vuralli Bakkaloglu D; Kepil N; Erdamar S
Bosn J Basic Med Sci; 2016 Nov; 16(4):254-260. PubMed ID: 27131021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
